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he Adult With Congenital Heart Disease
orn to Be Bad?
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The population of patients with adult congenital heart disease is approximately 800,000 in the
U.S. Those with prior cardiac surgery often consider themselves “cured,” although the
majority faces a lifetime of problems including arrhythmias, ventricular dysfunction, and one
or more re-operations. Even patients with repaired “simple” lesions such as an atrial septal
defect may not have normal survival if they are repaired in adulthood. Patients with repaired
coarctation may have premature cardiovascular complications including sudden cardiac death,
myocardial infarction, and stroke. They also have aortic complications such as aneurysm and
dissection, which result from a diffuse arteriopathy and continued hypertension that may be
caused by underlying endothelial dysfunction. In addition, bicuspid aortic valve occurs in
more than one-half of the patients with coarctation, so continued surveillance for significant
aortic valvular heart disease is necessary. More complex lesions also pose problems after “total
correction.” Patients with repaired tetralogy of Fallot often have pulmonary regurgitation,
which is frequently overlooked on clinical exam and echocardiography. Pulmonary valve
replacement should be performed before the development of irreversible right ventricular
dysfunction and an increased risk of ventricular tachycardia or sudden cardiac death. Because
they are vulnerable to deterioration of systemic ventricular function, those with congenitally
corrected transposition require special vigilance, usually with concomitant atrio-ventricular
valve regurgitation. Late referral is common with a deleterious effect on long-term survival.
These patients need lifelong follow-up and the residua and sequelae of their complex
anomalies must be understood in order to provide optimum care. (J Am Coll Cardiol 2005;
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.02.08346:1–8) © 2005 by the American College of Cardiology Foundation
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fhe last 50 years have witnessed dramatic changes for the once
hreatened and limited life of the baby born with congenital
eart disease. The advances in echocardiography, anesthesia,
ntensive care, and particularly cardiac surgery have facilitated
he survival of babies born with even the most complex cardiac
nomalies. Fifty years ago, only 25% of these infants would
urvive beyond the first year of life, but now more than 95%
ill survive to adulthood. This triumph of survival, which has
volved over the last few decades, has led to a “new population”
f adults with congenital heart disease. This population size is
stimated to be approximately 800, 000 in the U.S. (1).
Some patients may have mild defects and have never needed
urgery; in others, the defect may have been missed and may
ot be discovered until adulthood. The majority, however, have
ad previous cardiac surgery and may consider themselves
cured.” The perception of “cure” is fostered by the surgical
escription “total correction,” which is applied to many oper-
tive repairs of complex congenital anomalies. In reality, there
s almost no surgical cure for congenital heart disease, perhaps
ith the exception of a successfully ligated and divided ductus
rteriosus. All other repaired lesions have the potential for
esidua and sequelae, and although this may be a painful
ealization for patients and their families, it is a fundamental
From the Division of Cardiovascular Diseases and Pediatric Cardiology, Mayo
linic College of Medicine, Rochester, Minnesota.t
Manuscript received February 6, 2005; revised manuscript received February 15,
005, accepted February 22, 2005.nd important concept. The misperception of “cure” has
otentially serious consequences. Patients may forget to use
ntibiotic prophylaxis, are unlikely to endeavor to understand
he nature of their anomaly, and, much more importantly, see
o need to seek continued medical advice. As a result, residual
esions and sequelae are frequently overlooked until patients
resent with symptoms.
These patients are different from those with acquired heart
isease. One of the most common presentations is with an
rrhythmia, and cardiologists unfamiliar with congenital heart
isease often focus on the electrophysiologic aspects of the
ymptom complex, unaware of the underlying hemodynamic
roblems so commonly associated with the onset of arrhyth-
ias. In contrast to patients with acquired heart disease, who
sually notice a distinct change in symptoms at the onset of
heir problems, patients with congenital heart disease, having
ived with a lifelong cardiac problem, may not detect subtle
hanges in exercise capacity until they are significant. By the
ime the patients notice dyspnea and exercise limitation,
alvular residua and ventricular dysfunction are often severe
nd irreversible.
All of these challenges emphasize the importance of im-
ressing on patients, their families, and their physicians that all
ardiac surgery is palliative rather than curative and that
atients with congenital heart disease require lifelong
ollow-up at centers where expertise is available to deal with
heir complex problems. Two “simple” and two “complex”
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Adult Congenital Heart Disease July 5, 2005:1–8ongenital cardiac anomalies that support this thesis will be
eviewed.
TRIAL SEPTAL DEFECT (ASD)
urgical repair of secundum ASD has been performed since
954 and Murphy et al. (2) published the results of one of
he early pioneer series of symptomatic patients. They were
ollowed for 30 years, and patient survival was compared
ith age-matched control subjects (Fig. 1). Although pa-
ients in the younger quartiles (25 years) had normal
urvival, patients 25 years of age had a significantly
educed survival compared with control subjects, and this
as even more striking in those 40 years of age. Late
vents, including atrial fibrillation, stroke, and heart failure
ere more common in patients repaired in adulthood, and
his study was one of the first to demonstrate the benefits of
arly repair of secundum ASD in symptomatic patients.
hese residual problems after surgical repair in older pa-
ients have been confirmed in other studies (3–5). Presum-
bly, this relates to the long-standing deleterious effects of
olume overload on the right-sided cardiac chambers, pul-
onary hypertension, and right atrial enlargement that
ncrease the vulnerability to atrial arrhythmias and stroke. In
he series of Murphy et al. (2) 22% of late deaths were due
o stroke. Thus, although this common and simple cardiac
Abbreviations and Acronyms
ASD  atrial septal defect
AV  atrioventricular
BAV  bicuspid aortic valve
BP  blood pressure
eNOS  endothelial nitric oxide synthase
LV  left ventricle/ventricular
RV  right ventricle/ventricular
igure 1. Long-term outcome of patients surviving the perioperative peri
urvival in an age- and gender-matched control population is also shown. When
ompared with control subjects. Reprinted, with permission, from Murphy et anomaly can be easily repaired surgically and, in recent
ears, closed percutaneously, it is not completely “cured” and
s associated with ongoing morbidity and mortality.
OARCTATION OF THE AORTA
oarctation of the aorta is often regarded as a simple and
solated congenital anomaly, but is more correctly inter-
reted as part of a diffuse arteriopathy with a propensity to
neurysm formation and dissection remote from the coarc-
ation site (6). In addition, more than 50% of patients have
n associated bicuspid aortic valve (BAV) and 10% of
atients have cerebral aneurysms demonstrated on magnetic
esonance image scanning of the brain, suggesting a com-
on etiologic mechanism (7). After successful coarctation
epair, many patients consider themselves “cured,” and they
re often discharged from physician follow-up. It has long
een recognized that patients with repaired coarctation have
remature morbidity and even mortality (8,9). Late com-
lications are common, and long-term survival may be far
rom normal. A detailed knowledge of these complex
ssociations is critical in providing optimal care for these
atients.
The vulnerability of these patients to premature cardio-
ascular complications was exemplified in the largest series
ver reported after coarctation repair. Cohen et al. (8)
eported the long-term follow-up of 646 patients operated
n between 1946 and 1981. There were 17 perioperative
eaths, and 58 were lost to follow-up. Of 571 survivors, 67
atients had 81 subsequent cardiac operations, most fre-
uently for aortic valve replacement or re-coarctation. There
ere 87 late deaths, most commonly from acute myocardial
nfarction and sudden cardiac death, and the 30-year sur-
ival of this cohort was 72%. The mean age at death for this
simple” lesion was only 38 years. This emphasizes the
ontinued morbidity from premature coronary disease and
cording to age at operative closure of their atrial septal defect. Expectedod ac
patients undergo repair 25 years of age, survival is significantly reduced
l. (2).
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July 5, 2005:1–8 Adult Congenital Heart Diseaseesidual systemic hypertension, which is very common in
uch patients.
Other late cardiovascular complications requiring subse-
uent surgery are common. In two series from the Mayo
linic (8,10), the most common reason for re-operation was
ortic valve replacement, but mitral valve repair or replace-
ent in addition to re-operation for aortic aneurysm,
e-coarctation, and coronary artery bypass grafting are also
epresented. All of these congenital arterial abnormalities
oint toward a much more diffuse congenital cardiovascular
roblem than might be suspected from a superficial review
f this “localized” narrowing in the aorta.
esidual hypertension and vascular reactivity. At 30-
ear follow-up, as many as 75% of patients have residual
ystemic hypertension (11). The pathophysiology of residual
ypertension in such patients is poorly understood, and it
ccurs despite the absence of residual coarctation. Earlier
eports suggested that hypertension was less likely to occur
fter early repair (12), but more recent reports suggest that
ven after early repair, residual hemodynamic abnormalities
re common. O’Sullivan et al. (13) reported a 7- to 16-year
ollow-up of 119 children having coarctation repair at the
ge of 2 to 3 months. Of the patients, 28% had hypertension
t rest or during ambulation, including 21% who had no
esidual aortic obstruction.
Even patients with normal blood pressure (BP) at rest
ften demonstrate an abnormal systolic response to physical
xercise (14). This may contribute to increased left ventric-
lar (LV) mass that has been reported even in normotensive
atients after repair, and which, in and of itself, is another
mportant predictor of cardiovascular complications (15).
hether this increased LV mass is a genetically determined
ypertrophic response in coarctation or occurs because of
ersistent hemodynamic or hormonal abnormalities remains
o be determined. Contributing causes may be changes in
he arterial pressure wave propagation in the aorta and/or an
ncrease in aortic stiffness or a “re-programming” of the
ympathetic nervous and/or renin-angiotensin system (14).
Vascular reactivity and mechanical properties of large
pper limb conduit arteries also continue to be impaired,
ven in normotensive adults when successful coarctation
epair has been performed in the first few months of life
16). Studies examining the brachial artery response to
ow-mediated dilation after reactive hyperemia (induced
ither by inflation and deflation of a pneumatic cuff around
he forearm or administration of nitroglycerin) show less
ilation than in control subjects (14). Whether this repre-
ents early “programming” of vascular reactivity in utero or
n inherent arterial abnormality remains uncertain, but
learly this might contribute to persistent cardiovascular
bnormalities such as increased LV mass and diastolic
ysfunction (17).
This impaired arterial response to increased flow suggests
n underlying endothelial dysfunction, and nitric oxide may
lay a role in this regard and contribute to hypertension.
itric oxide is an important biological modulator that plays ssignificant role in vasodilation and BP control. Studies in
nimals have suggested a decreased nitric oxide bioavailabil-
ty in the aortic segment proximal to the coarctation with
p-regulation of endothelial nitric oxide synthase (eNOS)
n this region. In contrast, distal to the coarctation, nitric
xide activity is normal (18). This suggests a local barome-
hanical or endothelial etiology rather than a circulating
umoral factor that would be similar in both segments.
iffuse arteriopathy. This “simple” focal lesion also posed
esidual problems related to other areas of the arterial
ystem, which had a major impact on mortality and mor-
idity: stroke related to aneurysms of the Circle of Willis,
ortic aneurysm and dissection related to the inherently
bnormal aorta, and superimposed systemic hypertension
Fig. 2). Ascending aortic aneurysm is the most frequently
ncountered complication. Aortic complications resulting in
eath or the need for surgery are frequent during adult life
n patients with repaired coarctation. The co-existence of a
AV seems to influence their occurrence; in one series, the
revalence of aortic complications was 22% (29 of 134
atients) in those with a BAV compared with 8% (8 of 101
atients) in those without a bicuspid valve (19).
AV. Bicuspid aortic valve occurs in more than one-half of
he patients with coarctation and, therefore, periodic assess-
ent of possible aortic valve disease is warranted even after
uccessful coarctation repair. Bicuspid aortic valve is also
ne of the most common isolated congenital cardiac abnor-
alities, present in at least 1% of the population. Nitric
xide may also play a role in this pathophysiology, because
ice lacking eNOS appear more likely to develop a BAV,
lthough the mechanism remains uncertain. It is possible
hat valvular endothelium may generate signals that fine-
une the development of the primitive ventricular outflow
ract to ensure the development of a normal tricuspid
igure 2. Aortogram from a 40-year-old man with mild coarctation
gradient 18 mm Hg). The entire aorta is dilated (ascending aorta  40
m), and the arch vessels are also dilated, indicating a diffuse arterial
roblem.tructure (20). Similarly, nitric oxide has been implicated in
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Adult Congenital Heart Disease July 5, 2005:1–8ascular remodeling in response to changes in luminal flow
onditions; so lack of eNOS might also affect the modeling
f the aortic isthmus during transition from the fetal to
dult pattern of circulation. Whether a deficiency of the
ene encoding eNOS exists remains unproven, but these
bnormalities of nitric oxide in both BAV and coarctation
re tantalizing and do implicate a unifying etiology. Further
esearch in this area is necessary.
Bicuspid aortic valve is also an independent risk factor for
rogressive aortic dilation, aneurysm formation, and dissec-
ion. The aortic root dilation is unrelated to any hemody-
amic disturbance of the valve itself, because 50% of
oung patients with a functionally normal aortic valve have
chocardiographic evidence of aortic dilation (21,22). This
iagnosis, too, should prompt the beginning of lifelong
urveillance of the arterial tree. Both coarctation and BAV
re part of a spectrum of arteriopathy, and the search for a
ommon pathophysiology is tantalizing. Two possible cul-
rits include a genetic defect of fibrillin and/or an abnor-
ality of nitric oxide metabolism.
Medial changes in the ascending aorta have been well
emonstrated and are identical to the changes seen with
oarctation. Histologic examination reveals smooth muscle
ell loss, fragmentation of elastic fibers, and “pools” of
asophilic ground substance in areas of cellular loss. The
xact cause of these degenerative changes in the aorta is
ncertain, but apoptosis may be an important underlying
echanism causing the smooth muscle cell loss (23). There
ay be an underlying genetic stimulus for programmed cell
eath in the aortic media, and the recent observation that
AV is heritable supports this concept (24).
Interestingly, de Sa et al. (25) reported that degenerative
hanges in the media of the pulmonary artery are also more
ommon in patients with BAV, perhaps because the aorta
nd pulmonary artery share the same embryologic origin
rom the conotruncus. This would also support the concept
f a more diffuse “arteriopathy” and, perhaps, that BAV and
oarctation are part of a continuum of arterial abnormality.
Decreased levels of fibrillin-1 have also been reported in
he ascending aorta of patients with BAV, and this defi-
iency of fibrillin-1 may cause smooth muscle cells to detach
rom the elastic laminae with the release of matrix metal-
oproteinases. These matrix metalloproteinases weaken the
ortic wall, degrade the fibrillin-1, and contribute to the
ortic dilation (26). Although the gene for fibrillin-1 may be
tructurally normal in patients with BAV, it is possible that
ranscriptional elements that control protein production
ay be defective, thereby precipitating the arterial changes.
ollow-up. These important residua and sequelae support
he notion that patients with repaired coarctation need
ifelong follow-up with periodic imaging of the aortic valve
nd the entire aorta. Two-dimensional echocardiography is
articularly helpful in this regard, and echo-Doppler assess-
ent of the aorta facilitates measurement of the aorta,
oarctation site, and aortic valve. Magnetic resonance im-
ging provides a complementary adjunct to the evaluation jnd allows visualization of the entire aorta as well as
acilitating the detection of possible aneurysm formation at
he site of previous repair (usually not seen by echocardiog-
aphy or chest radiograph). Histologic abnormalities of the
scending aorta are common: the so-called “cystic medial
ecrosis,” in which there is fragmentation of the elastic
bers and accumulation of ground substance, making the
orta vulnerable to aneurysm formation and dissection.
Blood pressure control should be meticulous to minimize
hear stresses on the aorta; this should be evaluated both at
est and on exercise. Beta-blockade is ideal therapy in this
etting, although, as yet, there is no definite evidence that
hey prevent aortic dilation as demonstrated in the Marfan
yndrome (27). Ambulatory BP monitoring may be helpful
f there is doubt about the effectiveness of BP control (13).
areful attention should also be paid to BP at the time of
regnancy, because hormonal changes exacerbate the dis-
ensibility of connective tissues, including those in the aorta,
nd dissection and rupture of the aorta may occur during
regnancy, especially around the time of delivery.
ETRALOGY OF FALLOT
etralogy of Fallot is one of the most common cyanotic
efects encountered in infancy. Lillehei et al. (28) per-
ormed the first repair in 1954, and operative results from
ven the first 106 patients from the “pioneer era” were
xcellent with a 30-year survival of 91%. The original repair
nvolved closure of the ventricular septal defect and resec-
ion of muscle from the infundibular region of the right
entricular (RV) outflow tract (29). Because of the common
nding of a small annulus, however, subsequent repairs
ften involved either a patch across the RV outflow or the
lacement of a transannular patch. Although the patch is
ffective in relieving the obstruction, it distorts the pulmo-
ary valve apparatus and pulmonary regurgitation inevitably
esults.
ulmonary regurgitation. Pulmonary regurgitation is tol-
rated well for many years, even for decades, but the chronic
ffects of long-term volume overload of pulmonary regur-
itation eventually has a deleterious effect on RV function.
xercise capacity declines, secondary tricuspid regurgitation
ay occur, and supraventricular and ventricular arrhythmias
ay supervene. Sudden death may be the presenting fea-
ure. Patients often do not notice symptoms until RV
ysfunction is severe. There is also a “ventricular-ventricular
nteraction,” which occurs in the setting of RV enlargement
nd systolic dysfunction, and concomitant LV dysfunction
s often observed (30). The mechanism that links RV
ysfunction to LV dysfunction, however, is incompletely
nderstood.
Pulmonary regurgitation is frequently overlooked on
hysical examination, since the diastolic murmur is soft and
hort because there is rapid equalization of the diastolic
ressures in the pulmonary artery and RV. The regurgitantet is also frequently missed on two-dimensional echocardio-
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July 5, 2005:1–8 Adult Congenital Heart Diseaseraphy, because the jet has a low velocity and the flow is
aminar.
Any patient with previous surgical repair of tetralogy of
allot should have a normal heart size on chest radiograph,
nd the observation of an increased cardio-thoracic ratio
hould prompt a thorough search for a residual hemody-
amic lesion. This may be a residual ventricular septal
efect, aortic regurgitation, or pulmonary stenosis. The
ost common problem, however, is pulmonary regurgita-
ion, and pulmonary valve replacement is the most common
ndication for re-operation late after tetralogy repair (31).
bsence of symptoms does not reflect the functional de-
angement of the RV after tetralogy repair. Exercise testing
as demonstrated compromised exercise performance, and
emodynamic data show elevated RV end diastolic volumes
long with reduced cardiac output and ejection fraction in
atients with pulmonary regurgitation (32,33).
Pulmonary valve replacement can be accomplished with a
ow surgical risk (1% to 2%) in experienced centers, but
hould be performed before there is irreversible RV dys-
unction and the increased propensity for ventricular ar-
hythmias and sudden cardiac death (34,35). Timing of
ulmonary valve insertion is critical in reducing RV size,
reserving myocardial function, and preventing the devel-
pment of arrhythmias (35). The precise indication for
ulmonary valve replacement remains uncertain, although
ounting evidence suggests that in many centers it has been
erformed too late. Even when subjective improvement in
linical symptoms is noted there is often no improvement in
ither RV volumes or function (36). This must be balanced
gainst the concern of replacing the pulmonary valve early,
owever, which means the patient faces another re-
peration approximately 10 years later owing to structural
egeneration of the tissue prosthesis. Patients who require a
ulmonary valve replacement in the third or fourth decade
ay require several re-operations in their lifetime.
trial and ventricular arrhythmias. Arrhythmias are also
ommon sequelae of repaired tetralogy. Atrial arrhythmias
ay be present in approximately one-third of patients and
re a major source of morbidity (37). Although the preva-
ence of sustained ventricular tachycardia is low, it is
elieved to be responsible for the small but definite inci-
ence of sudden cardiac death in postoperative patients.
ulmonary regurgitation is the predominant underlying
emodynamic problem. Potential variables predictive of
eath include older age at repair, heart failure, residual or
ecurrent ventricular septal defect, and elevated RV pres-
ure. Ventricular ectopy is common in this patient popula-
ion, but neither frequent ectopy nor non-sustained ventric-
lar tachycardia on ambulatory Holter monitor reliably
dentifies patients at risk of ventricular tachycardia or
udden death. Right bundle branch block is the expected
attern on the electrocardiogram in 95% of patients, and a
mechano-electrical” association has been demonstrated,
howing that the larger the RV size, the greater the trend
oward a longer electrocardiographic wave (QRS) duration. bean QRS duration tends to be longer (180 ms) in
opulations of patients who die suddenly than in their
ealthy counterparts (38). The rate of late progression of
RS duration may also be a warning sign (39). Nonethe-
ess, these findings, although having significance in large
opulations of patients, have limited prognostic value in an
ndividual patient and have poor sensitivity and specificity.
The issue of whether electrophysiology studies are useful
o predict the development of clinical ventricular tachycar-
ia has also not been resolved. Failure to induce ventricular
achycardia may be interpreted as a favorable prognostic
ign, but a high proportion of patients have false-negative
tudies despite aggressive stimulation protocols (40). It has
een suggested that the inclusion of polymorphic ventricular
achycardia in the definition of inducibility improves the
ensitivity but with a slight reduction in specificity (41).
urthermore, no study has conclusively demonstrated that
nti-arrhythmic medication improves survival. Thus, risk
tratification in postoperative patients after tetralogy repair
emains a major challenge, and the indications for implan-
ation of a defibrillator device remain imprecise. Targeted
rrhythmia procedures at the time of pulmonary valve
eplacement utilizing intraoperative electrophysiological
apping and/or cryoablation appear to decrease the inci-
ence of arrhythmias, at least in the short term (42).
Thus, since the time of the first surgical repair of tetralogy
f Fallot, the operation has been referred to as “total
orrection.” This misnomer fosters the erroneous belief held
y patients that they are “cured” and that no further surgical
ntervention will ever be necessary. This may prevent them
rom seeking regular cardiac follow-up, so re-operation to
eplace the pulmonary valve is often performed later than
deal, when RV dysfunction is irreversible and patients are
ulnerable to arrhythmias and sudden cardiac death. Re-
entment is common when patients learn, to their dismay,
hat another operation is necessary.
RANSPOSITION OF THE GREAT ARTERIES
ND SYSTEMIC VENTRICULAR DYSFUNCTION
imple transposition (d-transposition). Ventricular dys-
unction is a common problem in many adults with con-
enital heart disease and is particularly common in those
orn with transposition of the great arteries. Simple trans-
osition (d-transposition) is the most common cyanotic
bnormality in newborns, in which the right atrium is
onnected to the RV (atrioventricular [AV] concordance)
hich, in turn, gives rise to the aorta (ventriculo-arterial
iscordance). The left atrium enters the LV, which gives
ise to the pulmonary artery. Since the 1980s, this defect has
sually been repaired in infancy with an arterial switch
rocedure so that the LV is restored to function as the
ystemic ventricle. In the 1960s, however, the only repara-
ive procedures were the Mustard or Senning operations
hat redirect the blood flow via an atrial baffle so that venous
lood is directed into the LV and then to the pulmonary
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Adult Congenital Heart Disease July 5, 2005:1–8rtery, and pulmonary venous blood is directed to the RV
nd thence to the aorta. These operations resulted in a
ramatic improvement in the lives of cyanotic infants, who
ere rendered pink and healthy, most of whom continue to
o well three decades later. Long-term problems are inev-
table, however, particularly as the morphologic RV contin-
es to function as the systemic ventricle This may function
ell for decades (43), but function deteriorates eventually,
ften with concomitant tricuspid regurgitation (44,45).
ulmonary artery banding to “retrain” the LV followed by
n arterial switch operation has provided improvement in
ystemic ventricular function in some young patients and
dolescents, but results of LV “conditioning” have been less
onsistent in adults (46). As a result, this approach has been
argely abandoned in adults in favor of cardiac transplantation.
ongenitally corrected transposition (l-transposition). A
imilar situation exists in those patients with congenitally
orrected transposition who have AV and ventriculo-arterial
iscordance; congestive heart failure is common by the
ourth and fifth decades (47). In this situation, the morpho-
ogic RV is also the systemic pump, and the systemic AV
alve (the tricuspid valve) is frequently congenitally abnor-
al and vulnerable to regurgitation. The diagnosis of
ongenitally corrected transposition may be missed by the
nwary physician who may overlook the abnormal position
nd appearance of the ventricles on echocardiography and
ail to observe the more inferior tricuspid valve (closer to the
ardiac apex) on the left side. The tricuspid valve always
nters a morphologic RV, and the leaflets insert directly into
he ventricles rather than having attachments to papillary
uscles. In one study from the Mayo Clinic (48), the
iagnosis of congenitally corrected transposition had been
issed in 7 of 44 adults who had had a cardiology
onsultation, despite the performance of one or more
maging studies (echocardiography and/or cardiac catheter-
zation). More importantly, most of these patients were
eferred to a tertiary care center late for an evaluation. Of 30
atients who needed a systemic AV valve replacement for
evere systemic AV valve regurgitation, 16 had 3/4 grade
V valve regurgitation and had established systemic ven-
ricular dysfunction for more than six months before refer-
al. Even though AV valve replacement can be accom-
lished at a relatively low risk in experienced hands,
entricular dysfunction has important prognostic implica-
ions. In one surgical series of 40 adult patients reported by
an Son et al. (49), the mean preoperative ejection fraction
as 48% (range 20% to 60%). There were four patients who
ied perioperatively, and in a mean follow-up of 4.6 years,
ight patients subsequently died. The cause of death in all
2 patients was ventricular failure. Survivorship correlated
ot only with more recent operations as surgical techniques
mproved, but more importantly, with pre-operative ejec-
ion fraction (ejection fraction 40%).
ollow-up. Therefore, it is imperative that patients with
ongenitally corrected transposition have a detailed evalua-
ion on a regular basis. This should include a physical txamination, chest X-ray, electrocardiogram, and echocar-
iogram performed by someone with expertise in imaging
omplex congenital anomalies. An increasing cardiothoracic
atio or deterioration of systemic ventricular function should
rompt a careful search for systemic AV valve regurgitation.
mplantation of an endocardial pacemaker may also warrant
ore frequent follow-up, because the change in septal activa-
ion causes septal “shift” and secondary dilatation of the
ystemic AV annulus and subsequent regurgitation (Fig. 3).
edical management. It is tempting to extrapolate the same
igure 3. (A) Chest radiograph of a 16-year-old young man with congen-
tally corrected transposition just after implantation of an endocardial
acemaker. Reportedly, his systemic ventricular ejection fraction was 40%,
nd he had moderate systemic atrioventricular valve (the tricuspid valve)
egurgitation. (B) Chest radiograph 18 months later at the time of referral.
is systemic ventricular ejection fraction was 15%, and he had severe
ystemic atrioventricular valve regurgitation. Cardiac transplantation was
he only viable surgical option, because the referral was too late for
onventional operation.reatment strategies for those with ventricular dysfunction with
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nd systemic (morphologic right) ventricular dysfunction. To
ate, however, there is very little evidence that administration
f angiotensin-converting enzyme inhibitors or beta-blockers
as a beneficial effect on exercise capacity, ejection fraction, or
ength of life in these patients (50). Indeed, some patients may
ave abnormalities of ventricular filling related to abnormal
ow through the atrial baffle. Patients with postoperative
ransposition and those with congenitally corrected transposi-
ion are particularly vulnerable to sinus node disease, and
njudicious use of beta-blockers may precipitate more profound
onduction disturbances and complete heart block. Multi-
enter trials are needed to determine the appropriate therapeu-
ic modalities for patients with congenital heart disease and
ystemic ventricular dysfunction when the RV functions as the
ystemic ventricle.
ONCLUSIONS
ll of the lesions discussed exemplify the notion that babies
orn with congenital heart disease are seldom “cured.”
espite the phenomenal advances in diagnostic, medical,
nd operative care that have occurred in the last 50 years,
any circulations still do not function normally, and resid-
al problems are common. Cardiologists throughout the
.S. still have little opportunity for exposure to adult
ongenital heart disease, and despite training recommenda-
ions, few trainees have the opportunity to see such patients
uring their fellowship. Many cardiologists, therefore, have
ittle understanding about the complexities of many post-
perative residua and sequelae.
Patients often have a poor understanding of their anat-
my and physiology and little concept of the possible
hallenges the future may hold. The surgical descriptor
total correction” fosters this misunderstanding, because
atients see little need to understand what was “fixed” and
o incentive to seek medical follow-up. Even when they do
eek follow-up, insurance obstacles often obstruct the path
o the few tertiary care centers where interdisciplinary
xpertise and resources are available. All patients confront
igure 4. Age of the patient population seen at the Adult Congenital
eart Disease Clinic at Mayo Clinic shown by decade. Of more than 3,000
atients, 38% are over 40 years of age. Pt  patient.any ongoing cardiac issues related to their congenital heart
isease, not to mention the impact that acquired hyperten-
ion, coronary artery disease, and other cardiovascular prob-
ems may impose on their underlying cardiac anomaly. This
ecomes an increasing problem as the population ages (Fig.
). In those who have had previous surgery, many face
ultiple re-operations in their lifetime (Fig. 5), and each
ubsequent operation poses an increasingly higher risk.
In conclusion, are these patients “born to be bad”? In
any ways, the answer is yes. They are seldom “cured” by
urgery and continue to have cardiac problems. Much time,
oney, and effort has been devoted to secure their survival,
nd unfortunately, very little thought has been given to
roviding for their long-term care. These survivors are
xtraordinarily courageous and usually, determined to work,
ontribute to society, and be as normal as possible. In
dulthood, they often receive no care or suboptimal care,
erhaps the worst of any cardiovascular subspecialty. The
ardiology community serves them poorly, and, as we look
o the future, we must make provision for lifelong care by
rained physicians with expertise in their complex problems.
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